LEADER 00917nam 2200337 450 001 990003428290203316 005 20100721130136.0 010 $a978-88-370-7332-9 035 $a000342829 035 $aUSA01000342829 035 $a(ALEPH)000342829USA01 035 $a000342829 100 $a20100721d2009----km-y0itay50------ba 101 $aita 102 $aIT 105 $a||||||||001yy 200 1 $aSubodh Gupta 210 $aMilano$cElecta$d2009 215 $a227 p.$cill.$d33 x 33 cm 300 $aPubblicato anche in inglese con lo stesso titolo 600 0 $aGupta,$bSubodh 676 $a790 801 0$aIT$bsalbc$gISBD 912 $a990003428290203316 951 $aXII.2.C. 1943$b222487 LM$cXII.2.C.$d00280859 959 $aBK 969 $aUMA 979 $aSENATORE$b90$c20100721$lUSA01$h1259 979 $aSENATORE$b90$c20100721$lUSA01$h1301 996 $aSubodh Gupta$91109717 997 $aUNISA LEADER 01175nam--2200397---450- 001 990002214490203316 005 20050225115948.0 010 $a1-58829-172-3 035 $a000221449 035 $aUSA01000221449 035 $a(ALEPH)000221449USA01 035 $a000221449 100 $a20041125d2004----km-y0enga50------ba 101 $aita 102 $aIT 105 $aa|||z|||001yy 200 1 $aDeath receptors in cancer therapy$fedited by Wafik S. El-Deiry 210 $aTotowa$cHumana Press$d20045 215 $aXI, 374 p.$cill.$d26 cm 225 2 $aCancer drug discovery and development 410 0$12001$aCancer drug discovery and development 454 1$12001 461 1$1001-------$12001 606 0 $aCancro$xAspetti molecolari 606 0 $aCancro$xTerapia 676 $a571.936 702 1$aEL-DEIRY,$bWafik S. 801 0$aIT$bsalbc$gISBD 912 $a990002214490203316 951 $a571.936 DEA$b3971 Farm.$c571.936$d00131640 959 $aBK 969 $aFAR 979 $aACQUISTI$b10$c20041125$lUSA01$h1253 979 $aFIORELLA$b90$c20050225$lUSA01$h1159 996 $aDeath receptors in cancer therapy$91031903 997 $aUNISA LEADER 02559nam 2200613 a 450 001 9910778311103321 005 20200520144314.0 010 $a1-84755-122-X 035 $a(CKB)1000000000791507 035 $a(EBL)1185670 035 $a(OCoLC)228415002 035 $a(SSID)ssj0000379435 035 $a(PQKBManifestationID)11300125 035 $a(PQKBTitleCode)TC0000379435 035 $a(PQKBWorkID)10366207 035 $a(PQKB)11471170 035 $a(MiAaPQ)EBC1185670 035 $a(Au-PeEL)EBL1185670 035 $a(CaPaEBR)ebr10621280 035 $a(PPN)198471513 035 $a(EXLCZ)991000000000791507 100 $a20060518d2004 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aLife saving drugs$b[electronic resource] $ethe elusive magic bullet /$fJohn Mann 210 $aCambridge, U.K. $cRoyal Society of Chemistry$dc2004 215 $a1 online resource (257 p.) 225 0$aRSC paperbacks 300 $aDescription based upon print version of record. 311 $a0-85404-634-8 320 $aIncludes bibliographical references (p. 233-240) and index. 327 $aLife Saving DrugsOFC; LSD_Pre-i-viii; LSD_Ch01_001_010; LSD_Ch02_011_084; LSD_Ch03_085_140; LSD_Ch04_141_222; LSD_Ch05_223_232; LSD_Further reading_233_240; LSD_Subject Index_241_248 330 $aIn 1900 only a handful of drugs (morphine, quinine, aspirin, etc) had genuine efficacy but had little value for bacterial or viral infections or cancer. These conditions were usually untreatable. Now there are literally thousands of drugs which offer cures or greatly extended life-spans for those with life-threatening conditions. Life Saving Drugs: the Elusive Magic Bullet describes the discovery and development of antibacterial, anti-viral and anti-cancer drugs. The book highlights the colourful characters behind the inventions and the huge improvements in quality of life and life-expectancy 410 0$aRSC Paperbacks 606 $aDrugs$xResearch$xHistory 606 $aPharmacology$xHistory 606 $aDrugs$xHistory 615 0$aDrugs$xResearch$xHistory. 615 0$aPharmacology$xHistory. 615 0$aDrugs$xHistory. 676 $a615.109 686 $a44.42$2bcl 700 $aMann$b J$0361539 712 02$aRoyal Society of Chemistry (Great Britain) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910778311103321 996 $aLife saving drugs$93766197 997 $aUNINA